Scribe Therapeutics Expands Collaboration With Biogen to Second Target

Go back to Scribe Therapeutics Expands Collaboration With Biogen to Second Target
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.96 +5.72 (2.94%)
Previous Close $194.24    52 Week High $333.65 
Open $195.49    52 Week Low $223.02 
Day High $201.18    P/E 25.60 
Day Low $194.24    EPS $7.81 
Volume 914,740